Company Profile

Smart Quotes

NECTAR LIFESCIENCES LTD.

NSE : NECLIFEBSE : 532649ISIN CODE : INE023H01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE23.921.33 (+5.89 %)

PREV CLOSE ( ) 22.59

OPEN PRICE ( ) 22.97

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 80783

TODAY'S LOW / HIGH ( )22.25 24.15

52 WK LOW / HIGH ( )20.05 56.39

NSE23.921.3 (+5.75 %)

PREV CLOSE( ) 22.62

OPEN PRICE ( ) 22.94

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 23.92 (3765)

VOLUME 975411

TODAY'S LOW / HIGH( ) 22.64 24.24

52 WK LOW / HIGH ( )20.02 56.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-06 1995

Management Info

Sanjiv Goyal - Chairman Sanjiv Goyal - Managing Director

Registered Office

Address Village Saidpura,Tehsil Dera Bassi,District Sahibzada Ajit Singh Nagar,
Mohali Dist,
Punjab-140507

Phone 01762-534001 / 534002

Email sales@neclife.com

Website www.neclife.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg

NEWS

05Apr Nectar Lifesciences informs about cert
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (..

04Apr Nectar Lifescience informs about discl
With reference to point no. 2 of Annexure 1 of letter no. NLL/CS/2024-43..

11Mar Nectar Lifesciences hits lower circuit
Nectar Lifesciences is locked at its lower circuit limit of Rs. 26.38, d..

11Mar Nectar Lifesciences receives 7 observa
European Directorate for the Quality of Medicines & HealthCare (EDQM..

28Feb Nectar Lifesciences informs about resi
Pursuant to Regulation 30 of the Securities and Exchange of Board of Ind..

Financials

in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	78.4	50.01
Gross Profit	125.47	182.75
Operating Profit	452.83	1661.35
Net Sales	4549.82	16856.32

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE) 5235.35 (2.88%)	M.Cap ( in Cr)8690.36
Divi's Lab (BSE) 6201.40 (2.16%)	M.Cap ( in Cr)164627.69
Sanofi India (BSE) 6042.35 (1.92%)	M.Cap ( in Cr)13915.91
Sanofi Cons. Health (BSE) 4992.75 (2.07%)	M.Cap ( in Cr)11498.61
Glaxosmithkline Phar (BSE) 2877.10 (3.12%)	M.Cap ( in Cr)48739.81

Shareholding Pattern

	NON-INSTITUTION	53.67%
	PROMOTERS	44.53%
	GOVERNMENT	0.02%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found